166
Views
6
CrossRef citations to date
0
Altmetric
Drug Evaluations

Exemestane in postmenopausal women with early or advanced breast cancer: a review

, MD PhD FRCP (Edin) &
Pages 1933-1942 | Published online: 23 Jun 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zhen Li, Kexin Liu, Pengyuan Sun, Lin Mei, Tangna Hao, Yan Tian, Zeyao Tang, Lei Li & Dawei Chen. (2013) Poly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for improved oral delivery of exemestane. Journal of Microencapsulation 30:5, pages 432-440.
Read now

Articles from other publishers (5)

Wojciech Szlasa, Natalia Janicka, Natalia Sauer, Olga Michel, Bernadetta Nowak, Jolanta Saczko & Julita Kulbacka. (2022) Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells. Frontiers in Immunology 13.
Crossref
B. J. Gregory, S. M. Chen, M. A. Murphy, D. H. Atchley & L. K. Kamdem. (2017) Impact of the OATP1B1 c.521T>C single nucleotide polymorphism on the pharmacokinetics of exemestane in healthy post-menopausal female volunteers . Journal of Clinical Pharmacy and Therapeutics 42:5, pages 547-553.
Crossref
Arturo Loaiza-BonillaFrancisco SocolaStefan Glück. (2013) Clinical Utility of Aromatase Inhibitors as Adjuvant Treatment in postmenopausal Early Breast Cancer. Clinical Medicine Insights: Women's Health 6, pages CMWH.S8692.
Crossref
June Koo LeeSeock-Ah ImDaewon LeeJi-Yeon KimYoojoo LimEunyoung LeeHyeong-Gon MoonTae-Yong KimSae-Won HanDo-Youn OhSe-Hoon LeeWonshik HanDong-Wan KimTae-You KimDong-Young Noh. (2013) Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors. Journal of Breast Cancer 16:1, pages 66.
Crossref
Muaiad Kittaneh & Stefan Glück. (2011) Exemestane in the Adjuvant Treatment of Breast Cancer in Postmenopausal Women. Breast Cancer: Basic and Clinical Research 5, pages BCBCR.S6234.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.